Conformal Medical has raised $32 million to support the development of its heart implant designed to reduce the lifetime risk ...

Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs ...

After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease (IBD) have been dashed. | Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease ...

Oric Pharmaceuticals’ previously announced plan to focus resources on its two most advanced oncology drugs comes with a sting ...

Generation Bio is shedding 90% of its workforce after the biotech acknowledged that it’s unlikely to find the cash to take ...

Clinical trial tech outfit Medidata has elevated a new strategy leader from within. | Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa ...

The director of the National Institutes of Health (NIH) has said the federal government’s discontinuation of mRNA vaccine ...

The company said its CGM+ system can deliver accurate readings across a 15-day lifespan, while also employing fewer ...

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...